Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression

Transplantation

Volumn 63, Issue 5, 1997, Pages 664-668

  Goldstein, Daniel J ^a,b   Zuech, Nancy ^a   Sehgal, Vinita ^a   Weinberg, Alan D ^a   Drusin, Ronald ^a   Cohen, David ^a  

^a Department of Surgery Columbia University ^*  (United States)

^b New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030898964     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00009     Document Type: Article

References (15)

1. Macoviak JA, Over PE, Stinson EB, Jamieson SW, Baldwin JC, Shumway NE. Four year experience with cyclosporine for heart and heart-lung transplantation. Transplant Proc 1985; 17 (suppl 2): 97.
2. Bertani T, Ferrazzi P, Schieppati A, et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant recipients. Kidney Int 1991; 40: 243.
3. Kaye MP. The long term effects of cyclosporine in heart transplant patients. Transplant Proc 1990; 22 (suppl 1): 12.
4. Hakim M, Wallwork J, English T. Cyclosporin A in cardiac transplantation: medium term results in 62 patients. Ann Thorac Surg 1988; 46: 495.
5. Myers BD, Sibley R, Newton L, et al. The long term course of cyclosporine associated chronic nephropathy. Kidney Int 1988; 33: 590.
6. Greenberg A, Thompson ME, Griffith BJ, et al. Cyclosporine nephrotoxicity in cardiac allograft patients: a seven year follow-up. Transplantation 1990; 50: 589.
7. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine associated chronic nephropathy. N Engl J Med 1984; 311: 699.
8. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
9. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187.
10. Oyer PE, Stinson EB, Jamieson SW, et al. Cyclosporine in cardiac transplantation: a 2 1/2 year follow up. Transplant Proc 1983; 15: 2546.
11. Waser M, Maggiorini M, Binswanger U, et al. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant 1993; 12: 846.
12. Kuo PC, Luikart H, Busse-Henry S, et al. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. Clin Transplant 1995; 9: 92.
13. Ruggenenti P, Perico N, Amuchastegui S, Ferrazi P, Mamprin F, Remuzzi G. Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. Am J Kidney Dis 1994; 24: 549.
14. United States Renal Data System 1995 Annual Data Report. Am J Kidney Dis 1995; 26 (suppl 2): S69.
15. Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995; 26: 193.